Yi Na Young, Newman Donna R, Zhang Huiying, Morales Johansson Helena, Sannes Philip L
a Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University , Raleigh , North Carolina , USA.
Exp Lung Res. 2015;41(9):499-513. doi: 10.3109/01902148.2015.1091053.
PURPOSE/AIM: Previous studies have indicated that the sulfated polysaccharide heparin has anti-inflammatory effects. However, the mechanistic basis for these effects has not been fully elucidated.
NCI-H292 (mucoepidermoid) and HBE-1 (normal) human bronchial epithelial cells were treated with LPS alone or in the presence of high-molecular-weight (HMW) fully sulfated heparin or desulfated HMW heparin. Cells were harvested to examine the phosphorylation levels of ERK1/2, p38, and NF-kB p65 and COX-2 protein expression by Western blot and gene expression of both COX-2 and CXCL-8 by TaqMan qRT-PCR.
Heparin is known to exert an influence on receptor-mediated signaling through its ability to both potentiate and inhibit the receptor-ligand interaction, depending upon its concentration. In H292 cells, fully-sulfated HMW heparin significantly reduced LPS-induced gene expression of both COX-2 and CXCL-8 for up to 48 hours, while desulfated heparin had little to no significant suppressive effect on signaling or on COX-2 gene or protein expression. Desulfated heparin, initially ineffective at preventing LPS-induced CXCL8 up-regulation, reduced CXCL8 transcription at 24 hours. In contrast, in normal HBE-1 cells, fully sulfated heparin significantly suppressed only ERK signaling, COX-2 gene expression at 12 hours, and CXCL-8 gene expression at 6 and 12 hours, while desulfated heparin had no significant effects on LPS-stimulated signaling or on gene or protein expression. Sulfation determines heparin's influence and may reflect the moderating role of GAG sulfation in lung injury and health.
Heparin's anti-inflammatory effects result from its nonspecific suppression of signaling and gene expression and are determined by its sulfation.
目的/目标:先前的研究表明,硫酸化多糖肝素具有抗炎作用。然而,这些作用的机制基础尚未完全阐明。
将NCI-H292(黏液表皮样)和HBE-1(正常)人支气管上皮细胞单独用脂多糖(LPS)处理,或在高分子量(HMW)完全硫酸化肝素或去硫酸化HMW肝素存在的情况下处理。收获细胞,通过蛋白质印迹法检测细胞外调节蛋白激酶1/2(ERK1/2)、p38和核因子κB p65(NF-κB p65)的磷酸化水平以及环氧化酶-2(COX-2)蛋白表达,并通过TaqMan定量逆转录聚合酶链反应(qRT-PCR)检测COX-2和CXC趋化因子配体8(CXCL-8)的基因表达。
已知肝素通过其增强和抑制受体-配体相互作用的能力对受体介导的信号传导产生影响,这取决于其浓度。在H292细胞中,完全硫酸化的HMW肝素在长达48小时内显著降低LPS诱导的COX-2和CXCL-8基因表达,而去硫酸化肝素对信号传导或COX-2基因或蛋白表达几乎没有显著抑制作用。去硫酸化肝素最初在预防LPS诱导的CXCL8上调方面无效,但在24小时时降低了CXCL8转录。相比之下,在正常HBE-1细胞中,完全硫酸化肝素仅在12小时时显著抑制ERK信号传导、COX-2基因表达,在6小时和12小时时显著抑制CXCL-8基因表达,而去硫酸化肝素对LPS刺激的信号传导或基因或蛋白表达没有显著影响。硫酸化决定了肝素的影响,可能反映了糖胺聚糖硫酸化在肺损伤和健康中的调节作用。
肝素的抗炎作用源于其对信号传导和基因表达的非特异性抑制,且由其硫酸化决定。